Whole Shine Medical Technology Co., Ltd. (SHE:002622)
China · Delayed Price · Currency is CNY 2.890
-0.030 (-1.03%)
At close: Feb 13, 2026
SHE:002622 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 752.99 | 861.13 | 756.62 | 500.6 | 167.98 | 114.3 |
Other Revenue | 0.44 | 0.44 | 0.09 | 0.05 | 0.13 | 0.05 |
| 753.43 | 861.57 | 756.71 | 500.65 | 168.11 | 114.35 | |
Revenue Growth (YoY) | -13.21% | 13.86% | 51.14% | 197.82% | 47.02% | -26.38% |
Cost of Revenue | 390.25 | 445.21 | 371.42 | 292.54 | 91.1 | 134.75 |
Gross Profit | 363.18 | 416.36 | 385.29 | 208.11 | 77 | -20.4 |
Selling, General & Admin | 333.06 | 353.1 | 296.4 | 262.75 | 72.53 | 46.74 |
Research & Development | 16.18 | 10.11 | 15.9 | 14.57 | 9.85 | 8 |
Other Operating Expenses | -1.68 | -1.84 | -2.93 | -2.42 | -1.58 | -3.98 |
Operating Expenses | 348.97 | 364.74 | 311.88 | 277.74 | 81.44 | 54.78 |
Operating Income | 14.21 | 51.63 | 73.42 | -69.64 | -4.44 | -75.18 |
Interest Expense | -40.93 | -42.88 | -44.63 | -62.6 | -38.82 | -40.21 |
Interest & Investment Income | 0.74 | 1.33 | 19.96 | 12.43 | 1.23 | 68.78 |
Earnings From Equity Investments | -18.84 | - | - | - | - | - |
Other Non Operating Income (Expenses) | 1.71 | -0.46 | -3.56 | -3.41 | -0.31 | -100.89 |
EBT Excluding Unusual Items | -43.12 | 9.62 | 45.19 | -123.21 | -42.34 | -147.5 |
Impairment of Goodwill | - | - | - | -21.19 | -14.72 | -155.19 |
Gain (Loss) on Sale of Investments | -3.7 | -3.7 | -91.79 | 66.39 | -17.43 | -1.78 |
Gain (Loss) on Sale of Assets | 0.82 | -0.58 | 4.17 | 0.88 | 0.03 | - |
Asset Writedown | 0.15 | -0.21 | -0.1 | -0.1 | - | -1.11 |
Legal Settlements | -13.46 | -13.46 | -13.42 | -215.27 | - | - |
Other Unusual Items | -9.54 | -0.96 | 1.84 | 2.56 | 4.59 | 3.97 |
Pretax Income | -68.85 | -9.29 | -54.11 | -289.94 | -69.86 | -301.61 |
Income Tax Expense | 6.1 | 5.95 | 4.15 | -9.73 | 3.97 | -4.49 |
Earnings From Continuing Operations | -74.94 | -15.24 | -58.26 | -280.22 | -73.83 | -297.12 |
Minority Interest in Earnings | -2.65 | -22.45 | -36.11 | 23.43 | -2.15 | - |
Net Income | -77.6 | -37.69 | -94.37 | -256.79 | -75.98 | -297.12 |
Net Income to Common | -77.6 | -37.69 | -94.37 | -256.79 | -75.98 | -297.12 |
Shares Outstanding (Basic) | 842 | 839 | 840 | 840 | 844 | 840 |
Shares Outstanding (Diluted) | 842 | 839 | 840 | 840 | 844 | 840 |
Shares Change (YoY) | 0.42% | -0.10% | 0.03% | -0.50% | 0.50% | 0.48% |
EPS (Basic) | -0.09 | -0.04 | -0.11 | -0.31 | -0.09 | -0.35 |
EPS (Diluted) | -0.09 | -0.04 | -0.11 | -0.31 | -0.09 | -0.35 |
Free Cash Flow | 27.65 | 78.57 | 103.4 | 8.26 | 12.63 | 64.75 |
Free Cash Flow Per Share | 0.03 | 0.09 | 0.12 | 0.01 | 0.01 | 0.08 |
Gross Margin | 48.20% | 48.33% | 50.92% | 41.57% | 45.81% | -17.84% |
Operating Margin | 1.89% | 5.99% | 9.70% | -13.91% | -2.64% | -65.75% |
Profit Margin | -10.30% | -4.38% | -12.47% | -51.29% | -45.20% | -259.85% |
Free Cash Flow Margin | 3.67% | 9.12% | 13.66% | 1.65% | 7.51% | 56.63% |
EBITDA | 32.89 | 69.89 | 91.12 | -50.55 | 7.57 | -62.86 |
EBITDA Margin | 4.37% | 8.11% | 12.04% | -10.10% | 4.50% | -54.97% |
D&A For EBITDA | 18.68 | 18.26 | 17.71 | 19.09 | 12.01 | 12.32 |
EBIT | 14.21 | 51.63 | 73.42 | -69.64 | -4.44 | -75.18 |
EBIT Margin | 1.89% | 5.99% | 9.70% | -13.91% | -2.64% | -65.75% |
Revenue as Reported | 753.43 | 861.57 | 756.71 | 500.65 | - | 114.35 |
Advertising Expenses | - | 115.09 | 104.5 | 94.22 | 8.15 | 0.05 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.